{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:09:09Z","timestamp":1774674549787,"version":"3.50.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Multiple Myeloma (MM) is the second most common malignancy of the hematopoietic system, accounting for approximately 10% of all hematological malignancies, and currently, there is no complete cure. Existing research indicates that exosomal long non-coding RNAs (lncRNAs) play a crucial regulatory role in the initiation and progression of tumors, involving various interactions such as lncRNA-miRNA, lncRNA-mRNA, and lncRNA-RNA binding proteins (RBP). Despite the significant clinical application potential of exosomal lncRNAs, research in this area still faces challenges due to their low abundance and technical limitations. To our knowledge, this review is the first to comprehensively integrate and elucidate the three mechanisms of action of exosomal lncRNAs in MM, and to propose potential therapeutic targets and clinical cases based on these mechanisms. We highlight the latest advancements in the potential of exosomal lncRNAs as biomarkers and therapeutic targets, offering not only a comprehensive analysis of the role of exosomal lncRNAs in MM but also new perspectives and methods for future clinical diagnosis and treatment of multiple myeloma.<\/jats:p>","DOI":"10.3389\/fonc.2024.1522491","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:10:38Z","timestamp":1737007838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma"],"prefix":"10.3389","volume":"14","author":[{"given":"Hong","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031649","article-title":"Multiple myeloma: challenges encountered and future options for better treatment","volume":"23","author":"Das","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.2021.25306","article-title":"What is multiple myeloma","volume":"327","author":"Silberstein","year":"2022","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: A review","volume":"327","author":"Cowan","year":"2022","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12254","article-title":"New insights into the interplay between long non-coding rnas and rna-binding proteins in cancer","volume":"42","author":"Yao","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-017-0706-8","article-title":"Role of exosomal proteins in cancer diagnosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00855-4","article-title":"The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer","volume":"54","author":"Wang","year":"2022","journal-title":"Exp Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014749","article-title":"Exosomes in multiple myeloma: from bench to bedside","volume":"140","author":"Menu","year":"2022","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100595","article-title":"The emerging role of exosomes in multiple myeloma","volume":"38","author":"Moloudizargari","year":"2019","journal-title":"Blood Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding rnas: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00694-9","article-title":"Transcription regulation by long non-coding rnas: mechanisms and disease relevance","volume":"25","author":"Ferrer","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12108","article-title":"Lncrna-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","article-title":"Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer","volume":"21","author":"Han","year":"2022","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","article-title":"Effects of exosomes on pre-metastatic niche formation in tumors","volume":"18","author":"Guo","year":"2019","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","article-title":"Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj8207","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112865","article-title":"Multiple myeloma cell-derived exosomes: implications on tumorigenesis, diagnosis, prognosis and therapeutic strategies","volume":"10","author":"Allegra","year":"2021","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030356","article-title":"The role of exosomes in human carcinogenesis and cancer therapy-recent findings from molecular and clinical research","volume":"12","author":"Stefa\u0144ska","year":"2023","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7150\/jca.31752","article-title":"Potential therapeutic roles of exosomes in multiple myeloma: A systematic review","volume":"10","author":"Li","year":"2019","journal-title":"J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci66517","article-title":"Bm mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of M(6)a methylation in adipocyte exosomal lncrnas mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jim-2019-001010","article-title":"Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve il-6 secretion of bmscs from multiple myeloma","volume":"68","author":"Liu","year":"2020","journal-title":"J Investig Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/path.5187","article-title":"Bone marrow fibroblasts overexpress mir-27b and mir-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes","volume":"247","author":"Frassanito","year":"2019","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s13018-023-04399-9","article-title":"Exosomal mir-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting sox6","volume":"18","author":"Long","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1038\/s41598-023-36092-6","article-title":"Cancer-associated fibroblast-derived exosome microrna-21 promotes angiogenesis in multiple myeloma","volume":"13","author":"Miaomiao","year":"2023","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-020-02468-9","article-title":"C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the mir-29b\/akt pathway","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-023-02741-x","article-title":"Involvement of lncrnas in cancer cells migration, invasion and metastasis: cytoskeleton and ecm crosstalk","volume":"42","author":"Ahmad","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103334","article-title":"Cerna in cancer: possible functions and clinical implications","volume":"52","author":"Qi","year":"2015","journal-title":"J Med Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","article-title":"Lncrna mir200chg inhibits emt in gastric cancer by stabilizing mir-200c from target-directed mirna degradation","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018471","article-title":"Rrol lncrna role in multiple myeloma","volume":"141","author":"Agirre","year":"2023","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding rnas and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5517","article-title":"Long non\u2212Coding rnas in multiple myeloma (Review)","volume":"62","author":"Yang","year":"2023","journal-title":"Int J Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding rna malat1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via mir-1271-5p\/sox13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgad053","article-title":"Malat1 regulates network of microrna-15a\/16-vegfa to promote tumorigenesis and angiogenesis in multiple myeloma","volume":"44","author":"Yan","year":"2023","journal-title":"Carcinogenesis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/atm-21-6710","article-title":"Knockdown of lncrna al928768.3 inhibits multiple myeloma cell proliferation by inducing cell cycle arrest in G0\/G1 phase","volume":"10","author":"Shen","year":"2022","journal-title":"Ann Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","article-title":"Lncrna H19 overexpression induces bortezomib resistance in multiple myeloma by targeting mcl-1 via mir-29b-3p","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14715\/cmb\/2020.66.6.14","article-title":"Long noncoding rna H19 promotes vincristine resistance in multiple myeloma by targeting akt","volume":"66","author":"Wang","year":"2020","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110058","article-title":"Abnormal expression pattern of lncrna H19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis","volume":"119","author":"Guo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0359-0","article-title":"Exosome-mediated transfer of lncrunx2-as1 from multiple myeloma cells to mscs contributes to osteogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.10.026","article-title":"Lncrna neat1 sponges mir-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma","volume":"117","author":"Gao","year":"2020","journal-title":"Mol Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106565","article-title":"Long non-coding rna linc01003 suppresses the development of multiple myeloma by targeting mir-33a-5p\/pim1 axis","volume":"106","author":"Wu","year":"2021","journal-title":"Leuk Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2975","DOI":"10.1038\/cddis.2017.358","article-title":"Lncrna oip5-as1 loss-induced microrna-410 accumulation regulates cell proliferation and apoptosis by targeting klf10 via activating pten\/pi3k\/akt pathway in multiple myeloma","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.11012","article-title":"Long noncoding rna irain acts as tumor suppressor via mir-125b in multiple myeloma","volume":"18","author":"Jiang","year":"2019","journal-title":"Oncol Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29726","article-title":"Roles of noncoding rnas in drug resistance in multiple myeloma","volume":"235","author":"Li","year":"2020","journal-title":"J Cell Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.Mcr-23-0282","article-title":"Exosomal lncrna neat1 inhibits nk-cell activity to promote multiple myeloma cell immune escape via an ezh2\/pbx1 axis","volume":"22","author":"Wang","year":"2024","journal-title":"Mol Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4855517","article-title":"Mesenchymal stem cells inhibit the effects of dexamethasone in multiple myeloma cells","volume":"2022","author":"Deng","year":"2022","journal-title":"Stem Cells Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jcyt.2018.10.006","article-title":"Exosome-transmitted linc00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microrna\/bcl-2 expression","volume":"21","author":"Deng","year":"2019","journal-title":"Cytotherapy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/ol.2022.13270","article-title":"Comprehensive analysis of competitive endogenous rnas network: identification and validation of prediction model composed of mrna signature and mirna signature in gastric cancer","volume":"23","author":"Ding","year":"2022","journal-title":"Oncol Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765382","article-title":"An oxidative stress-related gene pair (Ccnb1\/pkd1), competitive endogenous rnas, and immune-infiltration patterns potentially regulate intervertebral disc degeneration development","volume":"12","author":"Cao","year":"2021","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3892\/ol.2021.13104","article-title":"Comprehensive analysis of competitive endogenous rnas networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer","volume":"22","author":"Wu","year":"2021","journal-title":"Oncol Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1177\/1533033821989711","article-title":"Dysregulated lncrnas act as competitive endogenous rnas and are associated with cervical cancer development in uyghur women","volume":"20","author":"Chen","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102468","article-title":"Large-scale analyses identify a cluster of novel long noncoding rnas as potential competitive endogenous rnas in progression of hepatocellular carcinoma","volume":"11","author":"Song","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-13-0202","article-title":"Cerna cross-talk in cancer: when ce-bling rivalries go awry","volume":"3","author":"Karreth","year":"2013","journal-title":"Cancer Discovery"},{"key":"B56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12935-019-0817-y","article-title":"Construction and comprehensive analysis of a cerna network to reveal potential prognostic biomarkers for hepatocellular carcinoma","volume":"19","author":"Long","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2073130","article-title":"Role of exosomal competitive endogenous rna (Cerna) in diagnosis and treatment of Malignant tumors","volume":"13","author":"Mao","year":"2022","journal-title":"Bioengineered"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00934","article-title":"Integrated analysis of a risk score system predicting prognosis and a cerna network for differentially expressed lncrnas in multiple myeloma","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Genet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.625019","article-title":"Novel non-coding rna analysis in multiple myeloma identified through high-throughput sequencing","volume":"12","author":"Lu","year":"2021","journal-title":"Front Genet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122969","article-title":"Realization of osteolysis, angiogenesis, immunosuppression, and drug resistance by extracellular vesicles: roles of rnas and proteins in their cargoes and of ectonucleotidases of the immunosuppressive adenosinergic noncanonical pathway in the bone marrow niche of multiple myeloma","volume":"13","author":"Watanabe","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.06.003","article-title":"The multifaceted role of mesenchymal stem cells in cancer","volume":"60","author":"Timaner","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071635","article-title":"Recent progress of exosomes in multiple myeloma: pathogenesis, diagnosis, prognosis and therapeutic strategies","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11540","article-title":"Exosomal mrnas and lncrnas involved in multiple myeloma resistance to bortezomib","volume":"45","author":"Tang","year":"2021","journal-title":"Cell Biol Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230316152713","article-title":"Linc00461 knockdown enhances the effect of ixazomib in multiple myeloma cells","volume":"23","author":"Deng","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113239","article-title":"Emerging role of linc00461 in cancer","volume":"152","author":"Zhang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7424","article-title":"Downregulation of mirna-15a and mirna-16 promote tumor proliferation in multiple myeloma by increasing cabin1 expression","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs333","article-title":"Mir-15a and mir-16 affect the angiogenesis of multiple myeloma by targeting vegf","volume":"34","author":"Sun","year":"2013","journal-title":"Carcinogenesis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506654102","article-title":"Mir-15 and mir-16 induce apoptosis by targeting bcl2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1038\/s41467-021-24099-4","article-title":"The pan-cancer lncrna plane regulates an alternative splicing program to promote cancer pathogenesis","volume":"12","author":"Teng","year":"2021","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-022-03391-x","article-title":"The interaction between long non-coding rna linc01564 and pou2f1 promotes the proliferation and metastasis of gastric cancer","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.978375","article-title":"Natural antisense transcripts as drug targets","volume":"9","author":"Khorkova","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-613968","article-title":"Myeloma cell-derived runx2 promotes myeloma progression in bone","volume":"125","author":"Trotter","year":"2015","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-0284","article-title":"Runx2 deficiency in osteoblasts promotes myeloma progression by altering the bone microenvironment at new bone sites","volume":"80","author":"Xu","year":"2020","journal-title":"Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biochi.2018.12.006","article-title":"Parathyroid hormone-stimulation of runx2 during osteoblast differentiation via the regulation of lnc-supt3h-1:16 (Runx2-as1:32) and mir-6797-5p","volume":"158","author":"Arumugam","year":"2019","journal-title":"Biochimie"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203828","article-title":"Psma3-as1 induced by transcription factor pax5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging mir-376a-3p to up-regulate lamc1","volume":"14","author":"Sun","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s12885-021-08465-5","article-title":"Long non-coding rna psma3-as1 promotes glioma progression through modulating the mir-411-3p\/hoxa10 pathway","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000002136","article-title":"Long noncoding rna psma3 antisense rna 1 promotes cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via targeting microrna-154-5p to positively modulate karyopherin subunit alpha 4","volume":"51","author":"Bi","year":"2022","journal-title":"Pancreas"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-2363","article-title":"Exosome-transmitted psma3 and psma3-as1 promote proteasome inhibitor resistance in multiple myeloma","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1335330","article-title":"Recent insights into the functions and mechanisms of antisense rna: emerging applications in cancer therapy and precision medicine","volume":"11","author":"Rehman","year":"2023","journal-title":"Front Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1496742","article-title":"Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20s proteasomes","volume":"17","author":"Mittenberg","year":"2018","journal-title":"Cell Cycle"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for sirna delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J Control Release"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of sirna-based therapeutics: updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.64.1092","article-title":"Extracellular vesicle-mediated drug resistance in multiple myeloma","volume":"64","author":"Yamamoto","year":"2023","journal-title":"Rinsho Ketsueki"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.018","article-title":"Rna-binding proteins and cancer metastasis","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","article-title":"Rna-binding proteins in tumor progression","volume":"13","author":"Qin","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.02.004","article-title":"Rbp eif2s2 promotes tumorigenesis and progression by regulating myc-mediated inhibition via fhit-related enhancers","volume":"28","author":"Zhang","year":"2020","journal-title":"Mol Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-17-0605","article-title":"Long noncoding rna neat1, regulated by the egfr pathway, contributes to glioblastoma progression through the wnt\/\u03b2-catenin pathway by scaffolding ezh2","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03211-8","article-title":"Long noncoding rna neat1 promotes cardiac fibrosis in heart failure through increased recruitment of ezh2 to the smad7 promoter region","volume":"20","author":"Ge","year":"2022","journal-title":"J Transl Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.1ma0321-155rr","article-title":"Histone methyltransferase ezh2 negatively regulates nk cell terminal maturation and function","volume":"110","author":"Yu","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01336-5","article-title":"A tumor suppressor role for ezh2 in diffuse midline glioma pathogenesis","volume":"10","author":"Dhar","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","article-title":"Acetyl-coa synthetase 2: A critical linkage in obesity-induced tumorigenesis in myeloma","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13740","article-title":"Adipose exosomal noncoding rnas: roles and mechanisms in metabolic diseases","volume":"25","author":"Wu","year":"2024","journal-title":"Obes Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci Transl Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1100892","article-title":"Recent developments in isolating methods for exosomes","volume":"10","author":"Gao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12943-022-01648-z","article-title":"Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming","volume":"21","author":"Liang","year":"2022","journal-title":"Mol Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S453545","article-title":"Exosomes as powerful biomarkers in cancer: recent advances in isolation and detection techniques","volume":"19","author":"Zhang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-024-06494-z","article-title":"Roles of exosomes in immunotherapy for solid cancers","volume":"15","author":"Lyu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7150\/thno.64096","article-title":"The potential role of exosomal circrnas in the tumor microenvironment: insights into cancer diagnosis and therapy","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.01.046","article-title":"Role of exosomal non-coding rnas from tumor cells and tumor-associated macrophages in the tumor microenvironment","volume":"30","author":"Xu","year":"2022","journal-title":"Mol Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1344705","article-title":"Exosomes: A promising avenue for cancer diagnosis beyond treatment","volume":"12","author":"Wang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051465","article-title":"Exosomes: diagnostic and therapeutic implications in cancer","volume":"15","author":"Jo","year":"2023","journal-title":"Pharmaceutics"},{"key":"B102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jcmm.17126","article-title":"Non-coding rna-associated competitive endogenous rna regulatory networks: novel diagnostic and therapeutic opportunities for hepatocellular carcinoma","volume":"26","author":"Khashkhashi Moghadam","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000492846","article-title":"Long non-coding rna meg3 functions as a competing endogenous rna to regulate hoxa11 expression by sponging mir-181a in multiple myeloma","volume":"49","author":"Shen","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41419-020-2409-0","article-title":"Exosome-transmitted lncrna ufc1 promotes non-small-cell lung cancer progression by ezh2-mediated epigenetic silencing of pten expression","volume":"11","author":"Zang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S271795","article-title":"Exosomal lncrna ror1-as1 derived from tumor cells promotes glioma progression via regulating mir-4686","volume":"15","author":"Chai","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S435132","article-title":"M2 macrophage-derived exosomal lncrna mir4435-2hg promotes progression of infantile hemangiomas by targeting hnrnpa1","volume":"18","author":"Li","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1033143","article-title":"Circulating plasma exosomal long non-coding rnas linc00265, linc00467, uca1, and snhg1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113185","article-title":"Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression","volume":"10","author":"Saltarella","year":"2021","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5135445","article-title":"Multiple myeloma side population cells promote dexamethasone resistance of main population cells through exosome metastasis of lncrna snhg16","volume":"2023","author":"Yang","year":"2023","journal-title":"J Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e23924","DOI":"10.1002\/jcla.23924","article-title":"Baseline lncrna pcat1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients","volume":"35","author":"Zhao","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860849","article-title":"Patient-derived extracellular vesicles proteins as new biomarkers in multiple myeloma - a real-world study","volume":"12","author":"Ferreira","year":"2022","journal-title":"Front Oncol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e0210835","DOI":"10.1371\/journal.pone.0210835","article-title":"Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma","volume":"14","author":"Nielsen","year":"2019","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052126","article-title":"Lncrna-malat1: A key participant in the occurrence and development of cancer","volume":"28","author":"Hao","year":"2023","journal-title":"Molecules"},{"key":"B114","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","article-title":"Extracellular vesicle-packaged hif-1\u03b1-stabilizing lncrna from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells","volume":"21","author":"Chen","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","article-title":"Isolation and characterization of exosomes for cancer research","volume":"13","author":"Zhu","year":"2020","journal-title":"J Hematol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1522491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:10:44Z","timestamp":1737007844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1522491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":116,"alternative-id":["10.3389\/fonc.2024.1522491"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1522491","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"article-number":"1522491"}}